Authors
Latest:
Biopharma’s Role in Transforming the Oncology MarketplaceBiopharma must step up amidst growing oncology market.
Latest:
Unlock Real World Evidence with Pragmatic Data Governance and Quality PracticesHow companies are leveraging Real Word Evidence to evaluate therapies under real world conditions in a broader population at a lower cost than using Randomized Clinical Trials.
Latest:
Beyond Awareness: Modeling Shared Decision-Making in Patient CommunicationsWhen patients struggle to see a positive path forward, modeling a constructive journey can give them the confidence they need.
Latest:
Recent Federal Circuit Developments in Patent LicensingUnderstanding of recent legal developments can help companies avoid infringement.
Latest:
Digital Tools are Key to Advancing the Tech Revolution in PharmaTheir integration across enterprise remains pivotal driver for success.
Latest:
Impact, Access, and Scale: The Potential of India’s Pharma MarketCountry is poised to offer growth-channel opportunities for global pharma companies ready to scale access, innovation, and profitability.
Latest:
Strategic Realignment for a Better Future 1In adjusting to the long-term aftershocks from the coronavirus pandemic, pharma companies will need to focus on change in three core areas.
Latest:
The Future of Personalized Medicine Hinges on Pharma Executives Revolutionizing Business ModelsThe era of big pharma as product-first companies must end, as services become the larger priority.
Latest:
The Growth of International Arbitration in the Life Sciences SectorIn an unpredictable world, international life sciences collaborations can lead to misunderstandings and enforcement challenges, making an effective dispute resolution mechanism an essential risk management tool.
Latest:
Efficacy Controversy Hits European COVID-19 Vaccine RolloutDonald Macarthur and Dr. Meriem Bouslouk-Marx discuss post-approval findings of national committees in Europe charged with deciding the best strategy to use a new COVID-19 vaccine in their populations.
Latest:
The Need for Digital CME for Physicians Treating Patients with CLLIn the rapidly changing fields of medicine, such as hematology/oncology and specifically with respect to the management of patients with chronic lymphocytic leukemia (CLL), education is a key component of keeping clinicians current on changes to treatment paradigms.
Latest:
Enhancing Supply Chain Resilience amid Complexity in Pharma and Medical DevicesThe growing complexity of supply chains necessitates the adoption of collaborative planning processes and capabilities such as S&OP and S&OE.
Latest:
To Build AI Maturity, Start With Quick WinsCompanies must determine the right ways to utilize AI.
Latest:
The Importance of Collaborative Business Models for Drug DevelopmentInsights and examples of how collaborative efforts can lead to the development of innovative therapies that target unmet patient needs.
Latest:
Dynamic Compliance: The Best Defense for PharmaA proactive and tailored compliance department—with the nimbleness to adapt strategies on the fly—is a critical shield for life sciences companies during government investigations.
Latest:
Beyond Approval: Why Your Oncology Label Determines Commercial SuccessThe stakes have never been higher.
Latest:
How Agile Practices Can Enable Faster, Better Digital Health ProductsProviding ultimate value to stakeholders remains key in new style of development.
Latest:
As Pharma Continues to Adapt to AI, the POSA Standard will Need to Equally AdaptU.S. patent law will have to adapt to the use of AI in the life sciences industry.
Latest:
How Regulatory Affairs Is Shaping Tomorrow’s Innovation LandscapeAs regulatory reform continues to evolve in the US and Europe, the role of regulatory affairs is poised to help shape the more personalized treatment landscape on the horizon.
Latest:
Building Pharma and Lab Spaces in New Jersey 2021–Adapting to Changing NeedsNJ can regain leadership in pharma by offering modern lab spaces for biotech and other lab-based growth companies.
Latest:
Making the Case for Early-Stage Commercial AnalyticsAnalytics capabilities are no longer a nice-to-have, but a necessity to build and maintain a successful business and competitive edge.
Latest:
Q&A with Amy West, Head of US Digital Health & Innovation Strategy at Novo NordiskAmy West, Head of US Digital Health & Innovation Strategy at Novo Nordisk, shares her insights on fostering collaboration, embracing change, and her compelling vision to revolutionize digital transformation and innovation in the field of healthcare.
Latest:
Health Tech Companies Lead Charge for Greater AccessStay-at-home orders during the pandemic forced a shift in patient preferences—and the pharma industry has responded.
Latest:
HCPs & Virtual Meetings: What We LearnedAddressing the challenges created by virtual meetings with HCPs, what we have learned about virtual meetings so far, and a look into the future.
Latest:
Addressing the Knowledge Gap in Biologics & Biosimilars: Is a Board Certified Biologics and Biosimilars Program the Answer?Life sciences professionals will need to keep up with market demand for biologics and biosimilars.
Latest:
Delivering Brand Relevancy through Connected Data and AnalyticsHow a large, global biopharma company is leveraging a data-linking strategy to power insight-generation tools and techniques—and supporting customers through their journey with dynamic personalization and modular content.
Latest:
Learn how Pharmaceutical Excipients through MedicinesComplete can transform the way you workWebinar Date/Time: Thu, Oct 9, 2025 11:00 AM EDT
